Smith & Nephew
Corporate

Select your country

Smith & Nephew

Advanced Search
  • Home
  • About Us
  • Innovation & Products
  • Sustainability
  • Investor Centre
  • News & Media
  • Careers
  • Home
  • Innovation & Products
  • Key Products
  • Clinical Therapies
  • DUROLANE - Hyaluronic Acid, Stabilized Single Injection
  • Home >
  • Innovation & Products >
  • Key Products >
  • Clinical Therapies >
  • DUROLANE - Hyaluronic Acid, Stabilized Single Injection
  • EXOGEN Ultrasound Bone Healing System
  • DUROLANE - Hyaluronic Acid, Stabilized Single Injection
  • SUPARTZ Joint Fluid Therapy
  • Contact
  • Print
  • Forward

Email this page

close
  1. Mandatory fields are marked with an asterisk [*].

    Tell us who you want to send your mail to Fill in your email details

    Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.

    Change your message if you want Change the message if you want to

    1. <recipient name> <address>
    2. <sender name> <address>
    3. <sender name> is sending you a link

    4. <sender name>

    Visitor verfication

Email sent successfully
Error: Check all fields are valid. Exclude special characters from Comments field
Smith
Nephew

DUROLANE - Hyaluronic Acid, Stabilized Single Injection


DUROLANE®, currently approved in Europe and Canada, is a hyaluronic acid containing product used for the symptomatic treatment of mild to moderate knee and hip osteoarthritis. DUROLANE differs from SUPARTZ® and other multi-injection hyaluronic acid products in that one single injection represents a full course of treatment. Both products are used to supplement, or replace the natural hyaluronic acid found in healthy cartilage and synovial fluid. It acts as a lubricant and shock absorber in healthy joints and is an important weapon in the orthopaedic surgeon’s and rheumatologist’s armamentarium for treating osteoarthritis.

DUROLANE is often used in younger osteoarthritic patients who wish to remain active by cushioning the blow of knee or hip osteoarthritis to reduce pain and restore mobility and flexibility. For this reason DUROLANE is popular with sports medicine specialists to provide enduring pain relief safely and effectively. It is a NASHA (Non-Animal Stabilized Hyaluronic Acid) Gel containing product and is non-allergenic and non mutagenic.

 DUROLANE is unique in that it is the only single injection hyaluronic acid product on the market but it is also the only one in the world approved for hip osteoarthritis as well. US approval in the near future is expected.

® DUROLANE is a registered trademark of Q-Med AB

  • For more information on DUROLANE® click here
  • ◊ Trademark of Smith & Nephew
  • Accessibility
  • Terms of Use
  • Copyright & Disclaimer